In sheep, the steroid control of gonadotropin-releasing hormone (GNRH) release is sexually differentiated such that estrogen can trigger a GNRH surge and attendant reproductive behaviors in the female, but not the male. Furthermore, female lambs that have been exposed to testosterone during a critical window of in utero development are also unable to generate a GNRH surge. This study tests the hypothesis that exposure of the ovine fetus to androgens alters the development of key steroidreceptive neuronal inputs to the GNRH neurons. In adulthood, this results in reduced activation of specific neurons by estrogen in the male and testosterone-treated female. To make this determination, groups of ewes, rams, and testosterone-exposed ewes were treated with estrogen, and the activation of neurons in the mediobasal hypothalamus and brain stem determined by immunocytochemistry. A lower percentage of neurons in the ventrolateral aspect of the ventromedial nucleus (vlVMN) and the caudal arcuate nucleus (cARC), but not the brainstem, was activated by a 6-h exposure to estrogen in the androgenized and male animals. In the vlVMN, some of these neurons contain somatostatin; however, the phenotype of activated neurons in the cARC remains unknown. These data suggest that specific neural populations in these brain regions are involved in the estrogen feedback control of GNRH release in the sheep, and that the defeminization of the surge-generating system by in utero androgen exposure results, in part, from a failure of estrogen to activate key neural phenotypes.
INTRODUCTION
The components of the neural network that is responsible for the gonadotropin-releasing hormone (GNRH)/luteinizing hormone (LH) surge are poorly understood in any species. What is clear, however, is that the GNRH surge is triggered in female mammals by elevated concentrations of estrogen during the follicular phase of the reproductive cycle [1] [2] [3] . To understand the neural mechanisms by which this steroid hormone increases GNRH secretion, it is essential to determine where, and on which neural elements, estrogen acts. We know that estrogen probably does not exert its actions directly on the GNRH neurons, because they do not express estrogen receptor alpha (ESR1) [4] . Although estrogen receptor beta (ESR2) is present in GNRH neurons [5] , it is not thought to have a central action on the reproductive system [6] . Thus, information about the steroidal status of an animal must be relayed to the GNRH cells by ESR1-expressing intermediate neurons.
In the sheep, the control of the GNRH surge is sexually differentiated, and the male does not respond to follicularphase concentrations of estrogen with a surge of gonadotropin secretion [7] . This defeminization of the LH surge system is programmed in early fetal life, as female sheep that are exposed to androgens from Day 30 to Day 90 of gestation also fail to generate an LH surge in response to estrogen [8] . We know that prenatal androgen exposure also abolishes the GNRH surge [9] by preventing the activation of the GNRH neurons in response to estrogen stimulation [10] . However, the neural mechanisms by which in utero androgens result in defeminization of the ovine GNRH surge are unknown, and this is the focus of the present study.
In the normal ewe, there is good evidence from studies using estrogen microimplants that this steroid acts in the mediobasal hypothalamus (MBH) to elicit positive feedback [11] . This area of the brain contains several populations of neurons that show high expression of ESR1, including those that synthesize somatostatin (SST) and tachykinin 3 (TAC3; also known as neurokinin B [NKB] ). These are, therefore, good candidates for neurons that might be involved in the generation of the GNRH surge, as well as those the activity of which is altered by in utero androgen exposure. Within the ventromedial nucleus (VMN) of the MBH, about 35% of the SST neurons contain ESR1 [12] , and short-term estrogen treatment of ovariectomized (OVX) ewes increases mRNA expression for this neuropeptide [13] . In the caudal aspects of the MBH (the caudal arcuate nucleus [cARC] ) neurons that contain TAC3 are a sexually dimorphic population, essentially all of which contain ESR1 [14] . TAC3 mRNA expression is also altered by a short exposure of the OVX ewe to estrogen [15] . This population of TAC3 neurons is of further interest in the present study, because the cells have recently been shown to contain both kisspeptin and dynorphin A, both of which have been implicated in the steroid feedback control of GNRH release [16, 17] . Another population of ESR1-expressing neurons that have been implicated in estrogen feedback on GNRH release is located within the brainstem A1 and A2 cell groups, synthesize norepinephrine, and project to the preoptic area (POA), where the majority of ovine GNRH neurons are located [18] . In the OVX ewe, these cells are activated a few hours after the intramuscular administration of estrogen [19] .
In normal ewes, as stated above, SST, TAC3, and norepinephrine neurons are all activated in the early stages of the estrogen-stimulated GNRH surge. These determinations were made using immunocytochemistry for FOS, the protein product of the FOS gene, as a marker of neuronal activation. In the present study, we test the hypothesis that prenatal androgen exposure prevents activation of these neural phenotypes by estrogen, thus blocking the early stages of the GNRH surge induction process. Using a well-characterized animal model of the ovine follicular phase, we compare FOS activation of the VMN SST and cARC TAC3 neurons and the norepinephrine neurons of the A1 and A2 brain stem nuclei in normal females, normal males, and in utero androgen-exposed female sheep.
MATERIALS AND METHODS

Animals and Treatments
Thirty two spring-born lambs of the Poll Dorset breed (mean date of birth, 30 March 6 1.4 days) were raised at the Babraham Institute (528 12 0 N) near Cambridge, United Kingdom. Fourteen of the animals were control ewes, 7 were control rams, and 11 were ewes that had been exposed to androgens during fetal life by treating the mothers with biweekly injections of testosterone propionate (100 mg/injection [Sigma-Aldrich, Dorset, UK] in vegetable oil) between Days 30 and 90 of a 147-day pregnancy [20] . This treatment produces fetal T concentrations of approximately 0.5 ng/ml in females-a similar concentration to that observed in normal males [21] . The external genitalia are altered such that androgenized ewes have a penis, an empty scrotum, and a blind ending uterus with no vagina, as well as substantial disruption of the reproductive neuroendocrine axis [22] . All 25 ewes were ovariectomized during the breeding season, when approximately 19 mo of age (November). The androgenized animals exhibited disrupted reproductive cycles at this time.
Prior to the present study, ewes had been involved in an examination of the development of the LH surge, where details of reproductive cycles and responses to estrogen-positive feedback may be found [8] . Age-matched males were gonadectomized soon after birth using standard husbandry practices, and, immediately following gonadectomy, all animals were given a 1-cm-long Silastic implant filled with crystalline estrogen to maintain low physiological concentrations of the steroid. Procedures were approved by the Welfare and Ethics Committee of the Babraham Institute and performed under Home Office Project License PPL 80/1506.
Generation of Artificial Estrous Cycles
To confirm that the control ewes could generate an estrogen-induced LH surge, while none of the androgenized ewes could, artificial estrous cycles were generated in all 32 animals [23] . In March, animals were given progesterone for 9 days by subcutaneous implantation of a modified controlled internal drug release (CIDR) device (InterAG, NZ) under local anesthesia [20] . On Day 9, the progesterone implants were removed to simulate luteolysis, and 24-h later the animals were given four 3-cm-long Silastic capsules of estrogen (s.c.) that produce high follicular-phase concentrations of 7-12 pg/ml [24] . Samples of jugular blood were collected at hourly intervals for the first 6 h after estrogen, and at 3-h intervals between 6 and 33 h, and plasma was stored at À208C until assayed for LH. The four 3-cm-long estrogen implants were removed immediately after the collection of the last blood sample.
Collection of Brain Tissue
In mid-March, 3 days after removal of the estrogen implants from the first artificial estrous cycle, a second artificial cycle was begun with the s.c. implantation of a CIDR device to all 32 animals, which was removed after 9 days. After 24 h, half the females (positive controls, n ¼ 7), the androgenized females (n ¼ 11), and males (n ¼ 7) were given four 3-cm-long estrogen implants. Negative control females (n ¼ 7) were given blank implants. The timing of both progesterone and estrogen administration was staggered so that animals could be euthanized precisely 6 h after estrogen insertion. Animals were euthanized by barbiturate overdose (20 ml sodium pentobarbital [Lethobarb] ; Fort Dodge Animal Health, Southampton, UK), the heads removed and immediately perfused (over a period of about 20 min) via the carotid arteries with 0.5 L heparinized saline (75 IU/ml heparin in 0.9% sodium chloride), followed by 3 L of freshly made 4% paraformaldehyde/PBS using a Masterfix pump (CP instruments, Bishop Stortford, UK). A block of tissue (approximately 1.5 cm 3 ) containing the hypothalamus and POA was dissected, as was a similar-sized block of brainstem tissue containing the A1 and A2 nuclei, and postfixed overnight in the same fixative, transferred to a 30% sucrose/Tris-buffered saline (TBS) solution and stored at 48C.
Immunocytochemistry
Sections of hypothalamus and brainstem were cut on a freezing microtome (Leica model SM2400; Leica Instruments GmbH, Germany) at a thickness of 30 lm, placed in a cryoprotectant solution, and stored at À208C. Immunocytochemistry for SST was performed on sections selected from the VMN and POA, TAC3 used sections from the cARC at the level of the mamillary recess, GNRH used sections from the POA at the level of the organum vasculosum of the lamina terminalis (OVLT), ESR1 used sections from the cARC and VMN, and tyrosine hydroxylase (TH), as a marker for norepinephrine, used sections from the caudal portions of the ventrolateral medulla (A1) and the nucleus of the solitary tract (A2) in the ovine brain stem [25] .
SST, TAC3, GNRH, TH, and FOS single-labeled immunohistochemistry. The tissue was brought to room temperature, and free-floating sections were washed three times for 10 min in TBS to remove the cryoprotectant, followed by a 5-min incubation in 40% methanol/TBS/1%H 2 O 2 to inactivate endogenous peroxidases. Following three 10-min washes in TBS, sections were incubated in the relevant primary antibody (all validated in sheep) for 40 h at 48C; SST (1:2500, rabbit anti-SST-14 polyclonal; Peninsula Laboratories, CA [26] ), TAC3 (NKB) (1:6000, guinea pig polyclonal, IS-3/61; a gift from P. Ciofi [14, 27] ), GNRH (1:20 000, LR1; a gift from R. Benoit, Montreal, PQ, Canada [28] ), TH (1:40 000, mouse monoclonal anti TH MAB318; Chemicon International, Southampton, UK [29] ), and FOS (1:8,000, rabbit polyclonal, K25 sc-253; Santa Cruz Biotechnology, CA [30] ), all diluted in TBS/0.3% Triton X-100/0.25% BSA. The K25 FOS antibody reacts with FOS, FOSB, FOSL1 (Fra-1), and FOSL2 (Fra-2), and has been used previously in neuronal activation studies in the sheep [31, 32] . After incubation in primary antibody, sections were placed in an appropriate biotinylated second antibody for 90 min at room temperature (1:400; Vector Laboratories Ltd., Peterborough, UK), followed by 90 min in Vectastain Elite ABC kit (1:100 in TBS; Vector Laboratories Ltd.), and immunoreactive cells were visualized using diaminobenzidine (DAB) hydrochloride, which produces a brown cytoplasmic reaction product.
Double-labeled immunocytochemistry for FOS or ESR1 and SST, TAC3, or TH and GNRH/SST. In the case of double labeling with FOS or ESR1 (1:200, monoclonal mouse anti-human ESR1, clone ID5; DakoCytomation, Glostrup, Denmark [4] ) and another neuronal marker, the FOS/ESR1 immunocytochemistry was performed first, and the visualization of peroxidase performed with nickel-enhanced DAB (ni-DAB) to produce a black nuclear product. A second immunocytochemical procedure was then performed to stain for SST, TAC3, or TH using DAB alone, as described above. In the case of GNRH/SST, DAB was the chromagen for the former and ni-DAB for the latter. Cell bodies that were immunoreactive for GNRH were considered to be in close apposition to a SST fiber if the fiber was crossing or immediately adjacent to the perikarya in the same plane of focus using the 403 objective on the microscope [33] .
Data Analyses
Single-and double-labeled immunoreactive (ir) neurons were counted using a Leica DM RB microscope. For SST/FOS and TAC3/FOS, the microscope was fitted with an eye piece grid that highlighted a 0.5 mm 2 area when viewed using a 203 objective. The total number of SST-ir neurons was counted using a total of six randomly selected 0.5-mm 2 grids from the ventrolateral (vl) area of the VMN, and the percentage of double-labeled cells calculated. A similar process was used to calculate the number of TAC3-ir neurons in the cARC. The total number of GNRH-ir neurons in the POA at the level of the OVLT was determined in two sections, and the percentage in close apposition to an SST-ir fiber calculated. The total number of TH-ir neurons in the A1 and A2 brain stem nuclei was counted in two sections per nucleus, and the number and percentage of these cells that were FOS-ir was calculated. The mean number or percentage of single-or double-labeled cells was calculated for each group, and then statistically compared with ANOVA, followed, where appropriate, by a Tukey-Kramer multiple comparisons post hoc test. Data are presented as group means 6 SEM, and values were taken to be significantly different if P , 0.05.
Luteinizing Hormone Assay
LH was measured in duplicate aliquots of plasma (100 ll) using a modification of a previously described radio immunoassay [34, 35] . The primary antibody was NIDDK anti-ovine LH-1 (A.F. Parlow, National Institutes of Health, Bathesda, MD), and the standard was NIH-LH-S12. The intra-assay coefficient of variation was 7.2%, while the assay sensitivity was 0.2 ng/ml.
RESULTS
Reproductive Tracts at Time of Ovariectomy
The ovaries of all 14 controls showed signs of recent cyclic activity in the form of enlarged follicles, corpora lutea, or corpora albicantia. Of the androgenized animals, only 6 of the 11 164 showed signs of recent ovarian activity, which is significantly fewer (P , 0.01, Fisher exact test) than the controls.
Generation of Artificial Estrous Cycles
LH concentrations following estrogen administration in the OVX ewes and the rams during the 33 h of the first artificial cycle are shown in Figure 1A , and Figure 1B shows data from the first 9 h using an expanded scale. The mean concentration of LH was significantly higher (P , 0.001) in the males (2.74 6 0.30 ng/ml) compared with the control (0.84 6 0.29 ng/ml) and androgenized females (1.17 6 0.12 ng/ml) during the 6-h period immediately following estrogen administration. The administration of estrogen initially inhibited LH in all the animals, after which the 14 control ewes exhibited a robust surge of LH beginning, on average, 14.7 6 0.8 h postestrogen, and reaching mean peak concentrations of 34.1 6 3.3 ng/ml. None of the estrogen-treated males, and only 1 of the 11 androgenized females, produced an LH surge in response to exogenous estrogen. It is extremely rare in our flock of androgenized Dorset ewes for an animal to respond to elevated estrogen with an LH surge [8] , and, because this animal was an outlier, it was removed from the study. Although the males and androgenized females did not exhibit a surge release of LH, mean concentrations of LH in the period 9-33 h after estrogen were significantly elevated (P , 0.001) in the males (4.73 6 0.42 ng/ml) compared with the androgenized females (2.40 6 0.32 ng/ml).
Distribution of SST-ir Neurons and Fibers
The majority of SST-ir cell bodies were located in the vlVMN (Fig. 2a) . Very few stained cell bodies were located within the central portion of the VMN, although fiber staining in this region was considerable, such that the characteristic ''oval'' shape of the VMN could be clearly seen without the aid of a microscope. A more diffuse fiber plexus was found in the POA. The cARC was devoid of SST-ir cells. Neither the distribution nor the number of SST-ir cell bodies in the vlVMN differed among the four groups of sheep (data not shown).
GNRH Neurons and SST-ir Fibers in the POA
There were no significant differences among the groups in the number of detectable GNRH-ir neurons in the POA at the level of the OVLT. A large percentage of these GNRH-ir neurons (about 80%) were found in close apposition to at least one SST-ir fiber (see Fig. 2b ), and this percentage did not differ with sex or endocrine status.
Action of Estrogen on the Activity of GNRH-ir Neurons
A very low percentage (,2%) of GNRH neurons contained FOS-positive nuclei 6 h after the implantation of estrogen when LH concentrations were uniformly low, and this proportion did not differ across the four groups (data not shown). These data support those of an earlier study that showed that GNRH neurons are FOS-ir during the GNRH surge itself, but not at times when LH release is relatively low [36] .
Actions of Estrogen on the Activity of Neurons in the vlVMN
A substantial number of neurons in the vlVMN were FOSpositive following 6 h of exposure to estrogen, and this was significantly different across the groups (Fig. 2c) , with the estrogen-treated positive control group having over three times the number of FOS-ir neurons compared with the nonestrogen-treated negative controls (P , 0.01). Furthermore, the estrogen-implanted rams and androgen-treated ewes had a similar number of FOS-positive nuclei as the negative controls (P . 0.05), and this was significantly less than the positive controls (P , 0.05). To determine if SST neurons contributed to this difference in cell ''activation,'' the percentage of SST-ir cells that colocalized FOS was determined. About 30% of these cells colocalized ESR1, and this proportion did not differ across the groups (data not shown). Approximately one quarter of the SST-ir neurons exhibited FOS-ir nuclei in the positive control group (Fig. 2d) , which was significantly more (P , 0.05) than the negative controls and the androgenized ewes, which both had about half the number of dual-labeled cells. Although the percentage of activated neurons was less in the males than positive control females, it did not differ significantly from either the positive or negative controls.
Distribution of TAC3-ir Cells in the cARC
The distribution of TAC3-ir cells in the cARC was similar to that described previously [14] . In agreement with that study, we also found that the estrogen-treated females had signifi- FIG. 1. A) Mean LH concentrations (6SEM) in the estrogen implanted control ewes (square symbols; n ¼ 14), the males (triangular symbols; n ¼ 7), and the in utero androgenized ewes (circular symbols; n ¼ 7) during the 33-h period following estrogen administration in the first artificial cycle. B) Details of circulating LH concentrations in the same three groups of animals in the 9-h period following estrogen administration in the first artificial cycle (see hatched rectangle in A). The arrow indicates the time after steroid exposure when animals were killed in the experimental cycle. E, estrogen.
cantly more (P , 0.05) TAC3-ir cells than the males (Fig. 3a) . In addition, the number of TAC3/ESR1-ir neurons was greater in the females than the males (P , 0.05; Fig. 3b ). However, when this was viewed as a proportion of the total, the percentage of estrogen-receptive TAC3 neurons (about 95%) did not differ with sex (Fig. 3c) .
Action of Estrogen on the Activity of Neurons in the cARC
Cells immunoreactive for FOS and TAC3 are shown in Figure 4 , a and b. Following the 6-h exposure to estrogen, the number of FOS-ir cells in the cARC of the positive controls was double that of the negative controls ( Fig. 4c ; P , 0.05). Furthermore, the estrogen-exposed males and androgenized ewes had a similar number of FOS-ir neurons to the non-estrogen-treated negative control females ( Fig. 4c ; P . 0.05), which was also fewer than the positive controls (P , 0.05). Few of the TAC3 neurons colocalized FOS (,6%), and this proportion did not vary with sex or endocrine status (Fig. 4d) .
Distribution of TH-ir Cells and Fibers in the A1 and A2 Brainstem Nuclei
The distribution of immunopositive neurons in the brainstem nuclei was similar to that described previously [37] .
Action of Estrogen on the Activity of TH-ir Cells in the A1 and A2 Brainstem Nuclei
TH neurons in the A1 and A2 brainstem nuclei have been shown to synthesize norepinephrine [25] . Only cells in the caudal portions of both nuclei were analyzed, as these have the highest proportion of estrogen-receptive TH-positive cells [18, 38] . TH-positive neurons in the A1 nucleus are shown in Figure 5a , while cells double labeled for TH and FOS are depicted in Figure 5b . There were no significant differences 
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among the groups in the number of TH-ir cells in either nucleus (data not shown). In the A1 nucleus, the positive controls had about three times more double-labeled neurons compared with the negative controls (P , 0.01). However, the estrogen-treated males and androgenized females had similar or increased numbers of double-labeled cells (in the case of the androgenized ewes) compared with the positive controls, which were significantly greater (P , 0.01) than the negative controls. In contrast to the situation in the A1 nucleus, the percentage of FOS-positive TH-ir neurons in the A2 was low (about 5%), and did not change either with sex or endocrine status (Fig. 5d) .
DISCUSSION
The aim of the present study was to better understand the mechanisms by which in utero androgen exposure results in defeminization of the ovine GNRH surge-generating mechanism so that it cannot be triggered by elevated concentrations of estrogen in the male or in the ewe that has been treated in 
SEXUALLY DIFFERENTIATED GNRH SECRETION
utero with androgens [8] . The study was focused on three brain regions that have been shown to play vital roles in the steroid feedback control of GNRH release in the sheep: the VMN, the ARC, and the A1 and A2 nuclei of the brainstem. Within these regions, we have also focused on neurons that synthesize SST (VMN), TAC3 (cARC), and norepinephrine (A1 and A2), all of which have been implicated in the early events that lead to the preovulatory-like GNRH surge and sexual behavior. It should be made clear that the results and interpretation of our study will not differentiate between the action of estrogen to elicit steroid feedback on GNRH release or on estrous behavior, and further studies are underway in our laboratory to make this determination.
Several research groups have demonstrated that elevated estrogen concentrations are only required for a relatively short period to trigger the ovine GNRH surge and the accompanying reproductive behaviors [39] . While the duration and dose of steroid required varies with the sheep breed [40] , four 3-cmlong estrogen implants, present for 4-6 h, will reliably produce a GNRH surge in the Poll Dorset ewe [41] .
Our results show, for the first time, that neurons in the vlVMN and cARC, but not the brainstem, are activated in a sex-specific manner by a short-term exposure to estrogen. Furthermore, we have identified some of these sexually dimorphic neurons as those that synthesize SST.
In the sheep, estrogen microimplants that have been placed bilaterally into the MBH have provided evidence that this is the primary site of action of estrogen in inducing the GNRH surge and estrous behavior, and these were most effective when placed in the VMH [11, 42] . In our study, the estrogenimplanted males and in utero androgen-exposed females had about half the number of FOS-positive neurons in this region as the positive controls. Furthermore, this number was similar to the negative controls that were not treated with exogenous estrogen. As only the animals that are competent to produce a GNRH surge and estrous behavior exhibited increased FOS-ir, these data support the view that increased activation of neurons in the vlVMN is necessary for these key reproductive events. It also suggests that the neural mechanisms by which in utero androgens result in defeminization of the ovine GNRH surge and/or reproductive behavior include a failure of estrogen to activate key neurons, some of which are located in the vlVMN. This, in turn, leads to a lack of activation of the GNRH neuron itself [10] . This result is, however, in contrast with an earlier study, in which OVX Corriedale ewes were given an i.m. injection of estrogen benzoate (EB), and FOS was only detected in VMN neurons within the first 2 h, while no FOS was detected 6 h after injection [43] . This difference may relate to the method of estrogen administration (injection vs. implantation). However, it is also possible that this result is related to the progesterone treatment of the two groups of ewes, as the Corriedale ewes were not exposed to luteal-phase concentrations of progesterone before estrogen injection. This would have several consequences, as progesterone priming is known to delay, in a dose-dependant fashion, the time of onset of the GNRH surge after estrogen administration [44] to augment the maximum and mean concentrations of GNRH during the surge [45] , and to be necessary for the estrous behavior that accompanies the surge [46] . The chemical phenotype of the FOS-positive cells was unidentified in this study, although they did not colocalize adrenocorticotrophic hormone, TH, neuropeptide Y, or SST in the early period after estrogen injection [43] .
Our results demonstrate, for the first time, that SST neurons in the vlVMN are activated by a short exposure to estrogen in normal ewes. A similar short treatment with estrogen in OVX Ile de France ewes showed an increase in the expression of prepro-SST mRNA in the vlVMN [13] , and these data, taken together, strongly suggest that SST neurons in this brain region are directly regulated by estrogen. The VMN has been shown to be a target for the action of estrogen to induce the ovine GNRH surge, as well as proceptive and receptive behavior [11, 42] , and an anterograde study has described projections from this brain region to terminate in close apposition to about half of the GNRH cell bodies in the ewe [33] . In a recent study, we have used immunocytochemistry to determine that SST receptor (SSTR) 2 is colocalized within ovine GNRH neurons (P.H. Hastie, N.P. Evans, and J.E.R., unpublished data), while a murine study has identified mRNAs for Sstr2, Sstr3, and Sstr4 in diestrous female GNRH neurons [47] . Furthermore, it is clear that infusions of SST directly into the brain can alter LH secretion [13, 48] . Taking all these data together, we propose that the estrogen-responsive SST neurons in the vlVMN are a neural population that is activated in the early stages of the surge induction process, and may act directly on GNRH neurons in the POA via SSTR2. As the four other SSTRs (SSTR1, SSTR3, SSTR4, and SSTR 5) are also located in the POA close to GNRH neurons and fibers (P.M. Hastie, N.P. Evans, J.E.R., unpublished data), it is also possible that SST could have an indirect action on GNRH via as yet undefined neural populations. An earlier study in the anoestrous Dorset Horn ewe has demonstrated that a higher proportion of VMN SST neurons are activated 18 h after EB injection, just after the peak of the LH surge, than in noninjected control animals [49] . Whether these SST neurons are directly estrogen responsive is unclear. It is therefore possible that SST neurons activated in the early stages of surge generation are the 30% of SST neurons that contain ESR1, while those activated at the time of the GNRH surge belong to the 70% of non-ESR1-ir SST cells.
The ARC is an adjacent area to the VMN that may also be involved in the steroidal control of GNRH, either by being activated directly by estrogen, or receiving input from other estrogen-receptive neurons. A subset of ESR1-containing neurons project from the VMN to the ARC [50] , and implants of estrogen directly into this region elicit both negative and positive steroid feedback on LH release, actions that may be mediated by different neurons [11] . Following short-term estrogen exposure in the present study, double the number of neurons in the cARC were FOS-ir in the positive controls compared with the negative controls, the androgenized ewes, and the males. These data suggest that cARC neurons, like those in the vlVMN, are activated by short-term exposure to estrogen, and have the potential to be involved in the steroid feedback control of GNRH release. This hypothalamic region contains TAC3-synthesizing neurons that are sexually dimorphic (because of in utero androgen exposure), which is not the case for TAC3 neurons that are in a more rostral ARC location [14] . In the present study, a very low proportion (,6%) of these ESR-containing TAC3 neurons were FOS-positive, and this did not differ among the groups. These data are in accord with our earlier study on changes in cellular TAC3 mRNA levels in OVX ewes at specific time points after a surge, inducing administration of estrogen [14] in which no differences in TAC3 gene expression were noted 8 h after estrogen implantation, on the ascending limb, or at the peak of the GNRH surge. However, these findings are at odds with those of another study using a similar ovine model, in which 4 h of estrogen caused a decrease in TAC3 mRNA and the number of cells containing message [15] . Taken together, these studies might suggest that changes in TAC3 mRNA are relatively short lived, and are observed some 4 h, but not 8 h, 168 after estrogen. A recent study has shown that about 75% of TAC3 neurons in the cARC colocalized kisspeptin [16] , while about 85% of the cells colocalize dynorphin A [51] . These data would suggest that these subpopulations of kisspeptin and dynorphin A neurons in the cARC are not activated by shortterm estrogen treatment. However, if different subpopulations of TAC3/Kisspeptin/dynorphin A neurons are involved in negative and positive feedback on GNRH release, they may respond in a different manner to short-term administration of estrogen, and this would make interpretation of our data difficult. Data from long-term treatment of OVX ewes shows that KiSS1 mRNA expression is lower in the estrogen-treated OVX animals than the OVX controls [52] , while expression is enhanced in the cARC in the late, but not the mid-follicular, phase [53] . These data lead to the suggestion that a subpopulation of neurons in the cARC localize all three neuropeptides, which are activated close to the time of the GNRH surge. Although the present study suggests that these neurons are not activated by short-term estrogen exposure, if short-term estrogen caused a decrease in mRNA in some of these neurons, as it appears to do, then this may not appear as a change in FOS-ir.
TH-ir neurons in the A1 and A2 brain stem nuclei synthesize norepinephrine [37] , and about 20% of the norepinephrine neurons in the caudal portion of these nuclei express ESR1 [18, 38] . In addition, cells from the A1 nucleus projecting to the GNRH-rich POA express FOS after shortterm exposure to estrogen, and have therefore been implicated in the steroidal control of GNRH secretion [19] . However, unlike the situation in the rat, the A2 group of ESR1-ir norepinephrine neurons do not appear to project to the POA in the sheep [19] . The present study shows that short-term exposure to estrogen increases FOS in A1 TH-ir neurons, but not A2 neurons (where a very low proportion of TH-ir neurons were FOS positive), supporting a potential role for the former in the steroid control of GNRH release. In this case, all the animals treated with estrogen had increased FOS compared with the non-estrogen-exposed negative controls. Current data are consistent with the idea that the estrogen-responsive A1 norepinephrine neurons are important in the negative feedback action of estrogen, as this was also common to all estrogentreated groups. This idea is supported by a microdialysis study that showed that norepinephrine release in the ovine preoptic/ septal area was higher in ewes in which a GNRH surge had been triggered with estrogen than in control animals [54] . This was especially noteworthy during the 5-to 12-h period after steroid implantation, and before the GNRH surge began. These data do not preclude a role for A1 neurons in the estrogenpositive feedback or estrous behavior. However, as this was only observed in the positive controls in the present study, an intermediate neuron would have to be involved to transmit the estrogen signal from the A1 to the GNRH neuron, and the functioning of this neuronal population would then be altered by in utero exposure to androgens.
In summary, prenatal exposure of the ovine fetus to androgens during gestation results in the defeminization of the GNRH surge-generating system such that males and in utero androgen-treated ewes are unable to produce a GNRH/ LH surge or estrous behavior in response to follicular-phase concentrations of estrogen. Our studies have shown that a lower percentage of neurons in the vlVMN and the cARC are activated by short-term exposure to estrogen in the androgenized and male animals. In the vlVMN, some of these neurons contain SST; however, the phenotype of activated neurons in the cARC remains unknown. In the brain stem A1 (but not A2 nucleus), a similar number of norepinephrine neurons were activated by estrogen in the positive controls, androgenized ewes, and males-significantly more than in the negative controls. These data suggest that specific neural population in these brain regions are involved in the estrogen feedback control of GNRH release in the sheep, and that the defeminization of the surge-generating system by in utero androgen exposure results, in part, from a failure of estrogen to activate key neural phenotypes.
